Detalhe da pesquisa
1.
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.
Gut
; 64(6): 948-56, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25080450
2.
Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current Literature.
Curr Gastroenterol Rep
; 17(10): 462, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26342813
3.
Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials.
J Hepatol
; 61(2): 200-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24747798
4.
Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials.
Liver Int
; 34(5): 707-19, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118703
5.
Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant.
Clin Transplant
; 28(6): 722-7, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708229
6.
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
J Hepatol
; 56(2): 313-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703177
7.
Phase III results in Genotype 1 naïve patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin.
Liver Int
; 32 Suppl 1: 39-43, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212570
8.
Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation.
J Clin Gastroenterol
; 46(8): 700-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22739223
9.
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.
Lancet
; 376(9742): 705-16, 2010 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20692693
10.
Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
Hepatology
; 49(6): 1838-46, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291790
11.
Efficacy of chronic hepatitis C therapy in community-based trials.
Clin Gastroenterol Hepatol
; 7(10): 1028-36; quiz 1022, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447199
12.
Treatment of hepatitis C in liver transplant recipients.
Liver Transpl
; 15(2): 126-35, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19177439
13.
Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment.
J Transl Med
; 6: 66, 2008 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18986530
14.
Boceprevir and treatment of chronic hepatitis C.
Clin Liver Dis
; 17(1): 63-72, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23177283
15.
IDX184 in combination with pegylated interferon-α2a and ribavirin for 2 weeks in treatment-naive patients with chronic hepatitis C.
Antivir Ther
; 18(6): 755-64, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439365
16.
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trial.
Antivir Ther
; 18(3): 387-97, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406826
17.
Boceprevir: a user's guide.
Clin Liver Dis
; 15(3): 537-53, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21867935
18.
Intravenous interferon during the anhepatic phase of liver retransplantation and prevention of recurrence of cholestatic hepatitis C virus.
Liver Transpl
; 13(12): 1710-3, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18044743
19.
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial.
Hepatology
; 46(4): 971-81, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17894303
20.
Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1.
Hepatology
; 46(4): 982-90, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17894323